This study aimed to determine whether serum PCSK9 levels are increased in patients with the rare autoimmune liver diseases AIH, PBC, and PSC, and to assess whether PCSK9 levels are associated with disease severity, fibrosis stage, or sex. Here, PCSK9 is linked to primary biliary cholangitis.